B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Biosynthesis of DPAn-3-derived 13-series resolvins

REACTOME PATHWAY
Reactome: R-HSA-90264031 genes14 compounds

The Biosynthesis of DPAn-3-derived 13-series resolvins pathway (Reactome ID: R-HSA-9026403) involves 1 genes and is affected by 14 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

ALOX5

Compounds Affecting Biosynthesis of DPAn-3-derived 13-series resolvins

#CompoundTargets HitStudies
1Masoprocol300
2Quercetin300
3pterostilbene299
4piceatannol300
5butein158
6Celecoxib295
7caffeic acid300
8Kaempferols300
9Luteolin 5,7,3',4'-tetrahydroxy-flavone,150
10Resveratrol298
11Anthralin299
12Bufexamac137
13Indomethacin297
14Leukotriene A4 (2S-(2 alpha,3 beta(1E,3E,5Z,8Z)))-3-(1,3,5,8-Tetradecatetraenyl)oxiranebutanoic acid.300

About the Biosynthesis of DPAn-3-derived 13-series resolvins Pathway

The Biosynthesis of DPAn-3-derived 13-series resolvins pathway is catalogued in Reactome (ID: R-HSA-9026403) and involves 1 genes. In the BiohacksAI corpus, 14 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include ALOX5.